QCG
XENT

Quadrant Capital Group’s Intersect ENT, Inc XENT Stock Holding History

Quadrant Capital Group’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-55
Closed -$2K – 2852
2022
Q1 		$2K Hold
55
– – ﹤0.01% 2225
2021
Q4 		$2K Buy
+55
New +$1.49K ﹤0.01% 2220
2020
Q2 		– Sell
-2,148
Closed -$25K – 2477
2020
Q1 		$25K Hold
2,148
– – ﹤0.01% 1197
2019
Q4 		$53K Hold
2,148
– – 0.01% 1309
2019
Q3 		$36K Buy
+2,148
New +$39.1K 0.01% 1364

Quadrant Capital Group's XENT Position: Q2 2022 in Review

Quadrant Capital Group sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 55 shares — an estimated $2K sold.

Quadrant Capital Group first reported a position in XENT in Q3 2019 and held it in 5 quarters. The position peaked at $53K in Q4 2019. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Quadrant Capital Group reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Quadrant Capital Group sold 55 Intersect ENT, Inc shares in Q2 2022, an estimated $2K.
  • Quadrant Capital Group first reported a position in Intersect ENT, Inc in Q3 2019 and held it in 5 quarters.
  • Quadrant Capital Group's Intersect ENT, Inc position peaked at $53K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Quadrant Capital Group's 13F filing for Q2 2022, filed 9 Aug 2022.